{{Rsnum
|rsid=1800547
|Gene=MAPT
|Chromosome=17
|position=45974480
|Orientation=plus
|GMAF=0.1171
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MAPT
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 59.3 | 39.8 | 0.9
| HCB | 100.0 | 0.0 | 0.0
| JPT | 99.1 | 0.9 | 0.0
| YRI | 98.6 | 1.4 | 0.0
| ASW | 80.7 | 17.5 | 1.8
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 82.2 | 16.8 | 1.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 70.7 | 22.4 | 6.9
| MKK | 88.5 | 9.0 | 2.6
| TSI | 42.2 | 44.1 | 13.7
| HapMapRevision=28
}}

{{PMID|21425343|OA=1
}} replicates the association between [[rs1800547]] and late-onset [[Parkinson's disease]], calculating an odds ratio of 0.77 (CI: 0.66 - 0.88, p=3x10e-4) for the rarer [[rs1800547]](G) allele among 1445 patients from northern Spain.

{{PMID|18509094|OA=1
}} significantly associated with [[parkinson's disease]]

{{omim
|desc=MICROTUBULE-ASSOCIATED PROTEIN TAU; MAPT
|id=157140
|rsnum=1800547
}}

{{PMID Auto
|PMID=20951764
|Title=High cerebrospinal tau levels are associated with the rs242557 tau gene variant and low cerebrospinal beta-amyloid in Parkinson disease
}}

{{PMID Auto
|PMID=22104010
|Title=SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population
|OA=1
}}

{{PMID Auto
|PMID=19558713
|Title=Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.
|OA=1
}}

{{PMID Auto
|PMID=19763160
|Title=Genetic analysis of variation in human meiotic recombination.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}